Aoxin Q & M Dental Group (SGX:1D4) clarified its termination of Ong Siew Hwa as CEO of Acumen, citing the recent expiry of Acumen's lab license and the scheduled December closure of its Sengkang facility, which will leave it without revenue-generating operations, according to a Monday filing on the Singapore Exchange.
Acumen's board, with Aoxin's support, is exploring options including tendering for new contracts, reapplying for a lab license, or liquidating assets.
Aoxin's core business in China, spanning dental services and equipment distribution, remains unaffected.
Price (SGD): S$71.69, Change: S$+0.22, Percent Change: +0.31%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。